澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

RADIOPHARM THERANOSTICS LTD

0.022

0.000

成交量：54.62萬

成交額：1.21萬

市值：7,797.28萬

市盈率：-1.19

高：0.023

開：0.023

低：0.022

收：0.022

52周最高：0.040

52周最低：0.017

股本：35.44億

流通股本：28.56億

量比：0.17

換手率：0.02%

股息：- -

股息率：- -

每股收益(TTM):-0.018

每股收益(LYR):-0.018

淨資產收益率：-109.20%

總資產收益率：-27.70%

市淨率：1.74

市盈率(LYR):-1.19

資料載入中...

總覽公司新聞資訊公告

RADIOPHARM THERANOSTICS LTD可能會不定期發行及銷售最高可達5000萬美元的股票- SEC文件

RADIOPHARM THERANOSTICS LTD：在RAD 101二期B期腦轉移成像試驗中，92%的患者達到主要終點

Radiopharm Theranostics獲批准啓動RAD 402（Klk3-Mab與Tb161）在晚期前列腺癌中的一項I期治療試驗

Radiopharm Theranostics宣佈RAD101影像在腦轉移瘤的二期臨床試驗招募達到50%

Radiopharm Theranostics啓動177Lu-Rad204一期劑量遞增臨床試驗第三組招募

RADIOPHARM THERANOSTICS LTD - Rad 202一期試驗首個隊列顯示腫瘤攝取量超出預期

RADIOPHARM THERANOSTICS LTD 完成3500萬澳元孖展並推出500萬澳元股票購買計劃

RADIOPHARM THERANOSTICS LTD獲得數據安全監測委員會積極建議，加速推進177Lu-RAD202一期"Heat"劑量遞增臨床試驗

Radiopharm Theranostics Ltd與Starpharma達成研究與期權協議，共同開發創新放射治療資產

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RAD.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAD.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","market":"AU","secType":"STK","nameCN":"RADIOPHARM THERANOSTICS LTD","latestPrice":0.022,"timestamp":1771996320000,"preClose":0.022,"halted":0,"volume":546208,"delay":0,"changeRate":0,"nameEN":"RADIOPHARM THERANOSTICS LTD","floatShares":2856071021,"shares":3544216000,"eps":-0.018424,"marketStatus":"未開盤","change":0,"latestTime":"02-25 16:12:00 AEDT","open":0.023,"high":0.023,"low":0.022,"amount":12123,"amplitude":0.045455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.018424,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1772060400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.022,"openAndCloseTimeList":[[1771974000000,1771995600000]],"volumeRatio":0.1725557700527448,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RAD.AU\",,,,,undefined,":{"symbol":"RAD.AU","floatShares":2856071021,"roa":"-27.70%","roe":"-109.20%","lyrEps":-0.018424,"volumeRatio":0.1725557700527448,"shares":3544216000,"dividePrice":0,"high":0.023,"amplitude":0.045455,"preClose":0.022,"low":0.022,"week52Low":0.017,"pbRate":"1.74","psRate":"6.23","week52High":0.04,"institutionHeld":0,"latestPrice":0.022,"eps":-0.018424,"divideRate":0,"volume":546208,"delay":0,"ttmEps":-0.018424,"open":0.023,"prevYearClose":0.025,"prevWeekClose":0.022,"prevMonthClose":0.021,"prevQuarterClose":0.025,"fiveDayClose":0.022,"twentyDayClose":0.023,"sixtyDayClose":0.022,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAD.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAD.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAD.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1193463844","title":"RADIOPHARM THERANOSTICS LTD可能會不定期發行及銷售最高可達5000萬美元的股票- SEC文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1193463844","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193463844?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 06:14","pubTimestamp":1765923253,"startTime":"0","endTime":"0","summary":"RADIOPHARM THERANOSTICS LTD可能会不定期发行及销售最高可达5000万美元的股票- SEC文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"1159923558","title":"RADIOPHARM THERANOSTICS LTD：在RAD 101二期B期腦轉移成像試驗中，92%的患者達到主要終點","url":"https://stock-news.laohu8.com/highlight/detail?id=1159923558","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159923558?lang=zh_tw&edition=fundamental","pubTime":"2025-12-15 20:08","pubTimestamp":1765800493,"startTime":"0","endTime":"0","summary":"RADIOPHARM THERANOSTICS LTD：在RAD 101二期B期脑转移成像试验中，92%的患者达到主要终点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAD.AU","BK7067"],"gpt_icon":0},{"id":"1132004040","title":"Radiopharm Theranostics獲批准啓動RAD 402（Klk3-Mab與Tb161）在晚期前列腺癌中的一項I期治療試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1132004040","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132004040?lang=zh_tw&edition=fundamental","pubTime":"2025-11-18 19:12","pubTimestamp":1763464332,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics获批准启动RAD 402（Klk3-Mab与Tb161）在晚期前列腺癌中的一项I期治疗试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"1177466463","title":"Radiopharm Theranostics宣佈RAD101影像在腦轉移瘤的二期臨床試驗招募達到50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1177466463","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177466463?lang=zh_tw&edition=fundamental","pubTime":"2025-11-17 21:02","pubTimestamp":1763384530,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics宣布RAD101影像在脑转移瘤的二期临床试验招募达到50%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"1178925974","title":"Radiopharm Theranostics啓動177Lu-Rad204一期劑量遞增臨床試驗第三組招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1178925974","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178925974?lang=zh_tw&edition=fundamental","pubTime":"2025-11-12 21:31","pubTimestamp":1762954269,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics启动177Lu-Rad204一期剂量递增临床试验第三组招募","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAD.AU","BK7067"],"gpt_icon":0},{"id":"1119273096","title":"RADIOPHARM THERANOSTICS LTD - Rad 202一期試驗首個隊列顯示腫瘤攝取量超出預期","url":"https://stock-news.laohu8.com/highlight/detail?id=1119273096","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119273096?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 20:03","pubTimestamp":1760961790,"startTime":"0","endTime":"0","summary":"RADIOPHARM THERANOSTICS LTD - Rad 202一期试验首个队列显示肿瘤摄取量超出预期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"1170857665","title":"RADIOPHARM THERANOSTICS LTD 完成3500萬澳元孖展並推出500萬澳元股票購買計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1170857665","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170857665?lang=zh_tw&edition=fundamental","pubTime":"2025-10-20 19:31","pubTimestamp":1760959868,"startTime":"0","endTime":"0","summary":"RADIOPHARM THERANOSTICS LTD 完成3500万澳元融资并推出500万澳元股票购买计划","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU"],"gpt_icon":0},{"id":"1110725234","title":"RADIOPHARM THERANOSTICS LTD獲得數據安全監測委員會積極建議，加速推進177Lu-RAD202一期\"Heat\"劑量遞增臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1110725234","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110725234?lang=zh_tw&edition=fundamental","pubTime":"2025-10-01 20:02","pubTimestamp":1759320162,"startTime":"0","endTime":"0","summary":"RADIOPHARM THERANOSTICS LTD近日宣布，该公司收到了数据安全监测委员会(DSMC)的积极建议，决定加速推进177Lu-RAD202一期\"Heat\"剂量递增临床试验。\n这一积极的建议表明，该临床试验的安全性和有效性数据令监管机构满意，为公司进一步推进这一创新疗法的开发提供了有力支持。177Lu-RAD202作为公司核心在研产品，此次获得加速推进的建议将有助于更快地验证其治疗潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAD.AU","BK7067"],"gpt_icon":0},{"id":"1121801444","title":"Radiopharm Theranostics Ltd與Starpharma達成研究與期權協議，共同開發創新放射治療資產","url":"https://stock-news.laohu8.com/highlight/detail?id=1121801444","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121801444?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 18:17","pubTimestamp":1759227434,"startTime":"0","endTime":"0","summary":"Radiopharm Theranostics Ltd宣布与Starpharma达成研究与期权协议，双方将携手开发创新的放射治疗资产。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","RAD.AU","BK7501","BK7096","BK7508","SPL.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}